Patients with Immune Mediated Inflammatory Diseases Are Insufficiently Protected Against Vaccine-preventable Infections

Overview

Journal Infection

Date 2024 Aug 22

PMID 39172350

Authors

Natasja van de Pol

C Janneke van der Woude

Marijn Vis

Martijn B A van Doorn

Saskia L Schrauwen

Fatos Cetinozman-Teunissen

Rachel L West

Annemarie C de Vries

Affiliations

Soon will be listed here.

Abstract

Background: Patients with Immune Mediated Inflammatory Diseases (IMIDs) using immunosuppressive therapy are at increased risk of infections, including vaccine-preventable infections. In this study, we aimed to evaluate whether patients with IMIDs on systemic immunosuppressive therapy are vaccinated according to current guidelines.

Methods: A survey was sent out, between August 2022 and March 2023, to all patients with IMIDs that visited the departments of dermatology, rheumatology and gastroenterology at an academic and regional hospital in Rotterdam, the Netherlands. Patient-reported vaccination status was compared to the Dutch guidelines on vaccinations in patients with chronic inflammatory diseases.

Results: A total of 1,905/5,987 patients responded to the survey (response rate 32%). After exclusion of patients without systemic immunosuppressive medication, the study population comprised 1,390 patients, median age 56 years (IQR 42-66) and 41% male. Most patients (92%) had been vaccinated according to the Dutch National Immunization Program. Before starting immunosuppressive therapy, 2% of the patients who were still considered at risk according to the Dutch guideline were vaccinated for measles, and 4% for diphtheria/tetanus/polio (DT-IPV). Additionally, 62% of patients received an annual influenza vaccine, 16% received a five-yearly pneumococcal vaccine, and 91% were fully vaccinated against COVID-19.

Conclusion: Patients with IMIDs on immunosuppressive therapy are not vaccinated in accordance with the guidelines. Implementation strategies to improve the vaccination rates for patients with IMIDs should specifically focus on vaccinating against measles and diphtheria/tetanus/polio, and periodic vaccination against pneumococcal and influenza infections.

References

Malhi G, Rumman A, Thanabalan R, Croitoru K, Silverberg M, Steinhart A . Vaccination in inflammatory bowel disease patients: attitudes, knowledge, and uptake. J Crohns Colitis. 2015; 9(6):439-44. DOI: 10.1093/ecco-jcc/jjv064. View

Bridges M, Coady D, Kelly C, Hamilton J, Heycock C . Factors influencing uptake of influenza vaccination in patients with rheumatoid arthritis. Ann Rheum Dis. 2003; 62(7):685. PMC: 1754592. DOI: 10.1136/ard.62.7.685. View

Abreu C, Martins A, Branco E, Rocha R, Sarmento A, Magro F . Vaccines - beliefs and concerns: the voice of patients with inflammatory immunomediated diseases. Eur J Gastroenterol Hepatol. 2023; 35(8):848-853. PMC: 10476580. DOI: 10.1097/MEG.0000000000002589. View

Blumentals W, Arreglado A, Napalkov P, Toovey S . Rheumatoid arthritis and the incidence of influenza and influenza-related complications: a retrospective cohort study. BMC Musculoskelet Disord. 2012; 13:158. PMC: 3495205. DOI: 10.1186/1471-2474-13-158. View

Tinsley A, Navabi S, Williams E, Liu G, Kong L, Coates M . Increased Risk of Influenza and Influenza-Related Complications Among 140,480 Patients With Inflammatory Bowel Disease. Inflamm Bowel Dis. 2018; 25(2):369-376. DOI: 10.1093/ibd/izy243. View

Webb N, Lindsley J, Stockbridge E, Workman A, Reynolds C, Miller T . Effectiveness of an intervention to overcome influenza vaccine hesitancy in specialty clinic patients. Medicine (Baltimore). 2022; 101(30):e29786. PMC: 9333474. DOI: 10.1097/MD.0000000000029786. View

van Aalst M, Lotsch F, Spijker R, van der Meer J, Langendam M, Goorhuis A . Incidence of invasive pneumococcal disease in immunocompromised patients: A systematic review and meta-analysis. Travel Med Infect Dis. 2018; 24:89-100. DOI: 10.1016/j.tmaid.2018.05.016. View

Rahier J, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y . Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease. J Crohns Colitis. 2014; 8(6):443-68. DOI: 10.1016/j.crohns.2013.12.013. View

Coenen S, Weyts E, Jorissen C, De Munter P, Noman M, Ballet V . Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease. Inflamm Bowel Dis. 2017; 23(2):318-324. DOI: 10.1097/MIB.0000000000001013. View

10.

Wine-Lee L, Keller S, Wilck M, Gluckman S, Van Voorhees A . From the Medical Board of the National Psoriasis Foundation: Vaccination in adult patients on systemic therapy for psoriasis. J Am Acad Dermatol. 2013; 69(6):1003-13. DOI: 10.1016/j.jaad.2013.06.046. View

11.

Melmed G, Ippoliti A, Papadakis K, Tran T, Birt J, Lee S . Patients with inflammatory bowel disease are at risk for vaccine-preventable illnesses. Am J Gastroenterol. 2006; 101(8):1834-40. DOI: 10.1111/j.1572-0241.2006.00646.x. View

12.

Colmegna I, Valerio V, Gosselin-Boucher V, Lacoste G, Labbe S, Lavoie K . Barriers and facilitators to influenza and pneumococcal vaccine hesitancy in rheumatoid arthritis: a qualitative study. Rheumatology (Oxford). 2021; 60(11):5257-5270. DOI: 10.1093/rheumatology/keab471. View

13.

Furer V, Rondaan C, Heijstek M, Agmon-Levin N, van Assen S, Bijl M . 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2019; 79(1):39-52. DOI: 10.1136/annrheumdis-2019-215882. View

14.

Patel J, Noureldin M, Fakhouri D, Farraye F, Kovar-Gough I, Warren B . Interventions Increase Vaccination Rates in Inflammatory Bowel Disease and Rheumatoid Arthritis: A Systematic Review and Meta-Analysis. Dig Dis Sci. 2023; 68(7):2921-2935. PMC: 10079156. DOI: 10.1007/s10620-023-07903-7. View

15.

Kirchgesner J, Lemaitre M, Carrat F, Zureik M, Carbonnel F, Dray-Spira R . Risk of Serious and Opportunistic Infections Associated With Treatment of Inflammatory Bowel Diseases. Gastroenterology. 2018; 155(2):337-346.e10. DOI: 10.1053/j.gastro.2018.04.012. View

16.

Loubet P, Verger P, Abitbol V, Peyrin-Biroulet L, Launay O . Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study. Dig Liver Dis. 2018; 50(6):563-567. DOI: 10.1016/j.dld.2017.12.027. View

17.

Valerio V, Bazan M, Wang M, Mazer B, Pineau C, Hazel E . A multimodal intervention increases influenza vaccine uptake in rheumatoid arthritis. Clin Rheumatol. 2020; 40(2):575-579. DOI: 10.1007/s10067-020-05435-3. View

18.

Shigayeva A, Rudnick W, Green K, Chen D, Demczuk W, Gold W . Invasive Pneumococcal Disease Among Immunocompromised Persons: Implications for Vaccination Programs. Clin Infect Dis. 2015; 62(2):139-47. DOI: 10.1093/cid/civ803. View